Faron Pharmaceuticals Oy: Interim Results for the six months ended 30 June 2017
Faron Pharmaceuticals Ltd ("Faron" or the "Company") Interim Results for the six months ended 30 June 2017 INTEREST Phase III Traumakine® trial patient recruitment to complete in Q4 2017 and FDA advice received regarding advancement to …